JPMorgan Chase Financial Co. LLC has announced the pricing of $151,000 in Auto Callable Contingent Interest Notes linked to the common stock of Oracle Corporation. This strategic move is part of the company's efforts to expand its structured investment offerings, providing investors with new opportunities for potential returns.
The notes are designed for investors looking for contingent interest payments based on the performance of Oracle’s stock. The notes will pay a contingent interest rate of 15.45% per annum, contingent upon the stock's performance relative to a defined interest barrier. This structure aims to attract investors who are willing to accept certain risks in exchange for potentially higher returns.
Background
JPMorgan Chase Financial Co. LLC, classified under the SIC code 6021 for National Commercial Banks, is a wholly owned finance subsidiary of JPMorgan Chase & Co. The company is incorporated in Delaware and operates out of New York City. Its recent filings include several pricing supplements under the SEC Act, indicating ongoing activity in structured financial products.
What the Filing Says
According to the recent SEC filing dated October 29, 2026, the notes are fully and unconditionally guaranteed by JPMorgan Chase & Co. The filing details that the notes are designed to provide contingent interest payments if the closing price of Oracle's stock meets certain conditions. Specifically, the notes will be automatically called if the stock price meets or exceeds the initial value on any review date.
Impact
This offering may influence both investors and competitors in the national commercial banking sector. Investors are encouraged to evaluate the risks associated with these notes, including the potential for losing a significant portion or all of their principal. The structured nature of these notes may also prompt competitors to develop similar products to attract investors.
What's Next
The notes are expected to settle on or about October 30, 2026. Further details regarding the performance of these notes and their impact on the market will likely emerge as they begin trading.
For more information, refer to the SEC filing with accession number 0001918704-26-033252.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity










